PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.52
ESG score 90-95% of Healthcare median of 63.26. John Neff would demand higher returns to compensate for below-average ESG risk management.
60.80
Environmental score near Healthcare median of 59.42. David Dodd would investigate if industry-standard environmental practices adequately address climate risks.
59.46
Social score 90-95% of Healthcare median of 65.47. John Neff would demand higher returns to compensate for below-average stakeholder management.
58.31
Governance score 90-95% of Healthcare median of 64.59. John Neff would demand higher returns to compensate for below-average governance oversight.